Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana and currently employs 26,944 full-time employees. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. The company works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
¿Qué tal es el rendimiento del precio de la acción Dr. Reddy's Laboratories Ltd?
El precio actual de Dr. Reddy's Laboratories Ltd es de $12.82, ha aumentado un 2.92% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Dr. Reddy's Laboratories Limited?
Dr. Reddy's Laboratories Limited pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Dr. Reddy's Laboratories Limited?
La capitalización bursátil actual de Dr. Reddy's Laboratories Limited es $10.6B
¿Es Dr. Reddy's Laboratories Limited una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 39 analistas han realizado calificaciones de análisis para Dr. Reddy's Laboratories Limited, incluyendo 5 fuerte compra, 8 compra, 14 mantener, 11 venta, y 5 fuerte venta